Market Read®

  • Wednesday, July 09 2014

This prediction has hit its target!

As predicted, the stock moved down from $2.91 to $2.65 (-9.03%)
between March 11, 2013 and March 13, 2013.

This prediction has passed its maturity date!

This prediction was valid between March 11, 2013 and March 18, 2013. All information in this report is for reference only and should not be considered forward looking.

(NYSE: ENZ)

Enzo Biochem


Bearish

Enzo Biochem, Inc., an integrated life sciences and biotechnology company, is engaged in the research, development, manufacture, and marketing of diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. The company operates in three segments: Clinical Labs, Life Sciences, and Therapeutics. The Clinical Labs segment provides routine and esoteric clinical laboratory tests or procedures used in general patient care by physicians to establish or support a diagnosis, monitor treatment or medication, and search for an otherwise undiagnosed condition. This segment operates a full-service clinical laboratory in Farmingdale, New York; a network of approximately 35 patient service centers in New York and New Jersey; and a standalone laboratory in the New York, as well as a full-service phlebotomy, in-house logistics department, and information technology department. The Life Sciences segment manufactures, develops, and markets products and tools to life sciences, drug development, and clinical research customers. It offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide tools for target identification/validation, high content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis to life science researchers. This segment offers its products to scientific experts primarily in the fields of cancer, cardiovascular disease, neurological disorders, diabetes and obesity, endocrine disorders, infectious and autoimmune disease, hepatotoxicity, and renal injury. The Therapeutics segment is involved in research and development of therapeutic drug candidates in the areas of gastrointestinal, infectious, ophthalmic, and metabolic diseases. The company markets its products and services through its direct sales force. Enzo Biochem, Inc. was founded in 1976 and is headquartered in New York, New York.

Investment Highlights

  • EARNINGS predicts that ENZ will move down -7.76% by March 18, 2013. The target is $2.65. more
  • PATTERN SCAN predicts the price of ENZ expected to move down in the coming weeks based on the appearance of a 'Resistance Reversal(1)' pattern. Specifically, a ACT EOD variant of Resistance Reversal(1) has been detected. The target is $2.83. more
  • VALUATION ENZ has a current calculated value of $0.70 which means the stock is overvalued compared to its price of $5.15.

Predictive Range January 14, 2013 - March 18, 2013

Anticipated price movement, between prediction date and target date, based on all market reads.
$2.94 - $2.74

How WealthMakers Market Reads Work:

WealthMakers Market Reads™ provide you with market performance predictions based on proprietary technologies, trading algorithms and data to help you make better, more informed investment decisions. Here's a quick review of our predictive technologies:

  • EARNINGS Most stock price histories show random or unpredictable movements around earnings reports. But some repeat the same pattern quarter after quarter, year after year. Earnings predicts probability, price move and length of move before and after all US stock earnings reports.
  • FRICTION FACTOR Friction Factor is based on the relationship between the price of a stock and the volume at which it's bought and sold. Normal and abnormal Friction factor patterns can help you time your buying and selling decisions for maximum earnings potential.
  • GATS The Global Automated Trading System (GATS) combines neural networks and genetic algorithms to reduce investment risks. GATS selects the highest probability trades in stocks, bonds, options, commodities, currencies and private equities, delivering precise, predictive and profitable data.
  • GROUP SECTOR Certain institutions can exert buying or selling pressure over an entire industry group, pushing prices higher. Group Sector identifies stocks that most closely match their group's movement and generate powerful group consensus trading signals to help you profit from the herd mentality.
  • PATTERN SCAN This technology automatically tracks "Trigger Events" that positively or negatively affect the value of a stock — or its perceived value among analysts — ranging from price fluctuations to natural disasters and political shifts. The results reveal patterns that can predict market movements.
  • EVENTS Events describe the current technical situation in your stock. It displays the technicals, trend conditions and seasonal factors and automatically discovers how that stock has performed in the trading days following the occurrences of the event or combination of events. This technology automatically scans using complex historical queries based on what event is taking place right now in the stock. It then displays the probability, expected return and number of trading days for the expected move.
  • RegSHO NAKED SHORTS SEC Regulation SHO mandates that if a clearing agent holds a fail-to-deliver position for 13 consecutive settlement days, it must purchase securities to close out its position, a.k.a. a forced cover. WealthMakers aggregates data from NYSE, AMEX, NASDAQ, OTCBB and PINKSHEETS to track stocks that are about to have forced covers.
  • SEASONALITY Seasonality analyzes more than 20 years of data to determine if stocks have a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias.
  • SQUEEZE TRIGGER Our proprietary database of more than 3,500,000,000 short sale transactions allows us to calculate the exact price at which the total short interest is short in each stock. Squeeze Trigger Alerts let you know exactly when a short squeeze will start and how to trade profitably.
  • VALUATION A stock's value is a function of its forecasted earnings per share and forecasted earnings growth, as well as profitability, interest and inflation rates. Valuation use these metrics to determine at what price a stock is undervalued or overvalued, so that you can make investment decisions accordingly.
  • INSIDER Significant stock sales or purchases by company "insiders" (officers or directors) can be a predictor of future price movements — up or down. The Insider strategy tracks these actions and correlates them with historical data to give you an investment edge.

Earnings

 

Predicts probability, price move and length of move before and after earnings reports.

The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act after its earnings are released.
Earnings, or profits, drive stock prices. The market values a company based on its current and anticipated future ability to make money. The market takes the earnings pulse of a company four times per year when quarterly reports are issued. When this information is released it can often be a trend-changing or a trend confirming event because the information is so vital to the market's perception of the vitality of that company.
This technology is designed to help the stock trader identify those companies that seem to have a consistent pattern of movement before or after the earnings release date, based on the history

  • ENZ, currently trading around 5.15 expected to hit $2.65.
  • The price of ENZ tends to move down after earnings report dates.
  • Of the previous 6 earnings releases, ENZ has moved down 100% of the time.

Pattern Scan

 

Tracks "Trigger Events" that positively or negatively affect the value of a stock.

Enzo Biochem (NYSE: ENZ) is predicted to go down in coming weeks based on bearish technical trends that have appeared in the recent performance of the stock. ENZ has demonstrated Resistance Reversal(1) strategy ACT EOD with a strength of 1.0/5. The higher the strength, the higher the probability of an accurate prediction.

  • The price of ENZ expected to move down in the coming weeks.
  • PatternScan has detected that a 'ACT EOD' pattern has appeared.
  • Specifically, a ACT EOD variant of Resistance Reversal(1) has been detected.
  • This indicates a high probablity that ENZ will move down in the coming weeks.

Squeeze Trigger

 

We have a proprietary database of all trading in US stocks and maintain massive databases of short sale and naked short sale time and sales data, along with short squeeze SqueezeTrigger prices. We are the only firm that knows the exact price that a short squeeze will start in every US stock.

The Cumulative Squeeze Trigger price for ENZ is 3.84.

Date Short Volume Short Value SqueezeTrigger
2014-06-30 683439 3210659.7342 4.6978
2014-05-31 360121 1361725.5373 3.7813
2014-04-30 1242667 5327810.4958 4.2874
2014-03-31 1223502 4872474.3648 3.9824
2014-02-28 402192 1192338.4032 2.9646
2014-01-31 836507 2352843.2389 2.8127
2013-12-31 766956 2035501.224 2.654
2013-11-30 390147 936001.6677 2.3991
2013-10-31 497997 1211178.5037 2.4321
2013-09-30 175300 443263.58 2.5286
2013-08-31 690201 1664074.611 2.411
2013-07-31 261386 575859.4966 2.2031
2013-06-30 556946 1205286.8386 2.1641
2013-05-31 328679 746824.4238 2.2722
2013-04-30 461561 991386.8719 2.1479
2013-03-31 28974 83207.5332 2.8718
2013-02-28 241350 713454.735 2.9561
2013-01-31 334253 977556.3238 2.9246
2012-12-31 320248 866334.8896 2.7052
2012-11-30 1601979 4172194.1076 2.6044

Friction Factor

 

Friction Factor determines if there is normal or abnormal behavior in the price action of the stock when compared to the buying vs. selling trading statistics. It shows us how many more shares of buying than selling it takes to move a stock higher by 1 cent, or how many more shares of selling than buying it takes to drop a stock by 1 cent.
Here is how to understand Friction Factor:

  • If Friction Factor is positive, more buying than selling caused ENZ's price to rise
  • If Friction Factor is negative, more selling than buying caused ENZ's price to fall
  • If Friction Factor is 0, there was no discernable activity either way
  • If Friction Factor is abnormal, it means that more buying than selling caused the price to drop which is evidence of manipulative activity. In some cases more selling than buying can cause the price to increase. While this is rare, it must be noted as well. Friction Factor raw data.

Date Change Buy Vol Sell Vol Net Vol Friction
2014-06-25 0.08 136618 229794 -93176 Bullish Bias
2014-06-24 -0.3 109789 111551 -1762 -58.73333333
2014-06-23 -0.14 129193 132020 -2827 -201.9285714
2014-06-20 0.07 113404 98288 15116 2159.428571
2014-06-19 0.02 56733 89996 -33263 Bullish Bias
2014-06-18 -0.01 64417 104728 -40311 -40311
2014-06-17 0.07 249404 178234 71170 10167.14286
2014-06-16 0.18 269899 205887 64012 3556.222222
2014-06-13 0.13 126661 103442 23219 1786.076923
2014-06-12 0.08 104237 95951 8286 1035.75
2014-06-11 0.05 132661 109798 22863 4572.6
2014-06-10 0.12 188478 156620 31858 2654.833333
2014-06-09 0.23 84214 118652 -34438 Bullish Bias
2014-06-06 -0.04 85071 135655 -50584 -12646
2014-06-05 0.15 100276 145798 -45522 Bullish Bias
2014-06-04 -0.02 55568 67682 -12114 -6057
2014-06-03 0.14 84617 78124 6493 463.7857143
2014-06-02 0.28 183628 145342 38286 1367.357143
2014-05-30 0.3 98463 128149 -29686 Bullish Bias
2014-05-29 -0.1 32406 32878 -472 -47.2

Valuation

 

Value is a measure of a stock's current worth. ENZ has a current value of 0.7 per share. Therefore, it is overvalued compared to its Price of $5.15 per share. Value is computed from forecasted earnings per share, forecasted earnings growth, profitability, interest, and inflation rates. Value increases when earnings, earnings growth rate and profitability increase, and when interest and inflation rates decrease.

General Results

 

Past success in predictions regarding all predictions on the WealthMakers platform.

Our prediction engine has a track record that is second to none. See for our results.

Read Type Avg Return Avg Maturity Days Hits Misses % Accurate
Insider 15.127 73.12 9082 474 95.04%
SqueezeTrigger 12.737 22.37 7779 472 94.28%
Group Correlation 7.346 14.96 1308 88 93.70%
Valuation 14.484 26.96 4201 302 93.29%
Seasonality 7.458 15.2 42589 4126 91.17%
PatternScan 8.448 11.37 133305 19233 87.39%
Events 6.942 11.19 3387 543 86.18%
GATS 5.388 7.95 45028 8523 84.08%
Earnings 8.681 10.28 21679 4349 83.29%
Naked Shorts 14.491 10.83 2233 589 79.13%
Friction Factor 7.503 3.63 5599 1602 77.75%

Prediction Success

 

Past success in predictions regarding Enzo Biochem.

  • June 02, 2014 - Enzo Biochem Inc (NYSE:ENZ), Up By 8.06% ($0.31) After ${brandname}.com SqueezeTrigger Report Released on Friday, May 30th 2014 at a Price of $3.822.
  • May 14, 2014 - Enzo Biochem Inc (NYSE:ENZ), Up By 5.46% ($0.20) From $3.660 After ${brandname}.com Report Predicted Stock Would Go Up Due To Bullish Conditions

About Wealthmakers

WealthMakers gives institutional and individual investors an exclusive advantage in making precise, predictive and profitable trading decisions. Our proprietary technologies — Earnings, Seasonality, Squeeze Trigger, Group Sector and GATS — apply artificial intelligence, proprietary algorithms, market data and research to help our clients realize exponential returns. Find out more at WealthMakers.com.

All material herein was prepared by WealthMakers, based upon information believed to be reliable. The information contained herein is not guaranteed by WealthMakers to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. WealthMakers is not a registered investment advisor in the State of California. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. WealthMakers or its affiliates may receive compensation from independent third parties, or from the companies mentioned, for data provided in this report or related services. WealthMakers affiliates, officers, directors and employees do not own shares of the company mentioned in this report, but may from time to time buy/sell the shares discussed in this opinion and may profit from those trades. Market commentary provided by Thomas Ronk, a registered investment advisor and commodities trading advisor in California. WealthMakers will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment.

All Rights Reserved. Copyright 2011 WealthMakers

Overview
Last Price$5.15
52 Week Range$2.13 - $5.53
1 Month Range$4.60 - $5.53
Avg Daily Volume549875.0
PE Ratio0.0
 
Earnings Per Share
YearEPS
2014(E)$-0.238
 
Capitalization
Shares Outstanding43MM
Market Capitalization$232.70MM
 
 

QUESTIONS?

ACCOUNT SUPPORT 855-879-3258
EMAIL - support@wealthmakers.com